ASPEN AEROGELS INC quarterly report, Q1 FY2024

Aspen Aerogels, Inc. — Q1 2024 Form 10-Q

Reporting period: Three months ended March 31, 2024; comparison with Q1 2023. Aspen develops and manufactures aerogel insulation and thermal barriers for industrial and electric-vehicle battery applications.

Financial results and liquidity

MetricQ1 2024Q1 2023
Revenue$94.5 million$45.6 million
Gross profit / margin$35.1 million / 37%$5.1 million / 11%
Operating income (loss)$2.4 million$(18.9) million
Net income (loss)$(1.8) million$(16.8) million
Adjusted EBITDA (non-GAAP)$12.9 million$(13.9) million
Cash used in operations$(17.7) million$(24.7) million
Capital expenditures$(25.9) million$(49.4) million

Revenue more than doubled, primarily as thermal-barrier sales rose to $65.4 million from $11.7 million. Energy-industrial revenue declined 14% to $29.1 million. Thermal barriers were 69% of revenue, and energy industrial was 31%. Gross margin improved substantially, but the company remained loss-making after interest, taxes and other expenses. Basic and diluted loss per share was $0.02, versus $0.24.

At March 31, cash and cash equivalents were $101.5 million, down from $139.7 million at year-end; restricted cash was $0.2 million. Total assets were $698.0 million and stockholders’ equity was $491.2 million. The related-party convertible note had a $100 million principal amount and a $118.0 million carrying value; it matures in February 2027 and bears floating-rate interest. A $5.0 million equipment sale-and-leaseback was accounted for as financing, leaving a $4.8 million obligation. The company’s $100 million GM loan draw period expired without any borrowing.

Material changes and notable items

  • Thermal-barrier revenue increased 459%, while energy-industrial shipments fell 26% by square footage. Energy-industrial average selling price rose 16%, partly offsetting lower volumes.
  • Q1 cost of revenue included a $6.8 million net charge related to a customer engineering change and potential inventory and equipment obsolescence; the company submitted a reimbursement claim, with the customer’s audit expected to conclude in Q2 2024. Separately, $2.7 million of equipment-under-development impairment was reported in operating expenses. The filing also reports $6.0 million of total PP&E impairment, including $3.3 million in cost of revenue.
  • General and administrative expense rose 41% to $17.2 million, including a $2.0 million charge from cancellation of unearned performance-based awards. Interest and other expense included a $1.7 million write-off of GM-loan deferred financing costs after the draw period expired.
  • Two customers accounted for 64% of Q1 revenue; one customer represented 64% of accounts receivable at quarter-end.

Outlook, risks and contingencies

  • Management expects strong 2024 revenue growth, driven by EV demand and sustainable-insulation market-share gains, and expects net loss and negative Adjusted EBITDA to decrease. These expectations depend on customer production forecasts, successful scaling and supply availability.
  • Aspen is extending construction and commissioning of its Georgia plant to align capacity with expected EV demand and expects to substantially reduce planned 2024 capital expenditures until construction ramps up. Management cites a target revenue capacity of approximately $650 million in 2024, supported by Rhode Island productivity improvements and potential contract manufacturing in China; this is a capacity target, not a revenue forecast or guarantee.
  • Management says current cash should cover current operating needs, R&D and initial strategic capital expenditures, but anticipates additional funding for capacity expansion through possible equity or debt financing, leasing, customer prepayments or government programs. The filing reports $266.8 million of purchase commitments, including $202.7 million of capital commitments.
  • The DOE invited Aspen into formal due diligence and term-sheet negotiations for a potential loan related to the Georgia plant; no loan commitment is assured. GM thermal-barrier contracts specify no minimum purchase volumes and may be terminated by GM at any time.
  • Patent litigation continues. In April 2024, Korea’s Trade Commission found asserted composition claims invalid and process claims not infringed; Aspen may appeal, and related proceedings continue. A former Polish distributor’s claims are stayed pending arbitration. The company reported no litigation loss probable for which an accrual was required.
  • Other risks include reliance on major customers, manufacturing and supply-chain execution, cost inflation and potential financing needs. The filing states disclosure controls were effective and reports no material change in internal control over financial reporting.

Important facts for investors to verify

  • Whether EV customer demand and production schedules support thermal-barrier growth, and how customer concentration changes.
  • Whether the engineering-change reimbursement is approved and how much of the $6.8 million charge is recovered.
  • Actual 2024 cash burn, capital spending and financing requirements as Georgia construction timing changes.
  • Availability, cost and reliability of China contract manufacturing and progress toward the stated capacity target.
  • Developments in DOE loan negotiations, GM contract volumes, and the related-party note’s interest and potential dilution terms.
  • Outcomes of the Korea and Poland proceedings and any resulting costs or business effects.